Core Viewpoint - The company plans to acquire an additional 18% stake in Suzhou Jiazhi Color Optoelectronics Technology Co., Ltd. for a total price of 171.5958 million yuan, increasing its ownership from 51% to 69% [2] Group 1: Transaction Details - The acquisition involves Suzhou Caiqi Enterprise Management Partnership (Limited Partnership) and Suzhou Yuancai Enterprise Management Partnership (Limited Partnership) [2] - The transaction is classified as a related party transaction and has been approved by the company's board of directors [2] - The deal is pending approval from the upcoming extraordinary general meeting of shareholders [2] Group 2: Strategic Implications - The acquisition is expected to enhance the operational management efficiency and employee cohesion of Jiazhi Color [2] - The transaction aligns with the interests of the company and all shareholders [2]

Core Viewpoint - Entropy Technology (301330.SZ) has announced the acquisition of 55% equity in Shenzhen Longzhiyuan Technology Co., Ltd. for RMB 416.35 million, marking a strategic expansion for the company [1] Group 1: Acquisition Details - The company approved the acquisition during the 22nd meeting of its third board of directors held on October 17, 2025 [1] - The acquisition involves purchasing shares from multiple shareholders, including Yu Mengchu, Li Weihua, and others [1] - Following the acquisition, Longzhiyuan will change from a joint-stock company to a limited liability company, which is a prerequisite for the transaction [1] Group 2: Corporate Changes - Longzhiyuan has completed the necessary business registration changes and has been renamed Shenzhen Longzhiyuan Technology Co., Ltd. [1] - After the completion of the business registration, Longzhiyuan will become a subsidiary of the company and will be included in the company's consolidated financial statements [1]

格隆汇11月18日｜和顺石油发布异动公告，公司股票价格于2025年11月14日、11月17日连续两个交易日 内收盘价格涨幅偏离值累计超过20%，属于股票交易异常波动情况。公司以现金方式，通过收购股权及 增资购买上海奎芯集成电路设计有限公司不低于34%的股权，同时通过表决权委托，合计控制标的公司 51%表决权，即取得标的公司的控制权。本次签订的意向协议系双方基于收购事项达成的初步意向，具 体交易方案、交易金额以最终签署的正式收购协议为准。 ...

智通财经APP讯，巍华新材(603310.SH)发布公告，公司控股子公司浙江方华化学有限公司(以下简称"方 华化学")拟以现金方式收购浙江欣禾生物股份有限公司(以下简称"欣禾生物")持有的江苏禾裕泰化学有 限公司(以下简称"禾裕泰"或"目标公司")70%的股权，交易对价1.54亿元，资金来源为自有资金及银行 贷款。本次交易完成后，禾裕泰将成为公司控股孙公司。 标的公司现有产品耗用的其中3个主要原料，是上市公司及控股子公司的主要产品，目前标的公司向上 市公司及外部供应商都有采购。本次股权收购后，公司将为标的公司这些原料提供稳定的供应支撑，既 减少外部采购环节的不确定性，也能通过内部协同优化生产节奏，提升整体运营效率及收益。 标的公司目前仍处于亏损阶段，核心原因系农化产品市场价格持续低位波动，叠加产能利用率不足。不 过亏损态势已呈现改善迹象，2025 年上半年亏损额较上年同期有所收窄，第三季度经营情况进一步向 好。本次收购完成后，将通过大力拓展销售渠道、进一步提升产能利用率、优化产品工艺、强化内部运 营管理等措施，力争标的公司在2026年度开始实现扭亏为盈，并在未来持续创造稳定收益。 ...

标的公司目前仍处于亏损阶段，核心原因系农化产品市场价格持续低位波动，叠加产能利用率不足。不 过亏损态势已呈现改善迹象，2025 年上半年亏损额较上年同期有所收窄，第三季度经营情况进一步向 好。本次收购完成后，将通过大力拓展销售渠道、进一步提升产能利用率、优化产品工艺、强化内部运 营管理等措施，力争标的公司在2026年度开始实现扭亏为盈，并在未来持续创造稳定收益。 标的公司现有产品耗用的其中3个主要原料，是上市公司及控股子公司的主要产品，目前标的公司向上 市公司及外部供应商都有采购。本次股权收购后，公司将为标的公司这些原料提供稳定的供应支撑，既 减少外部采购环节的不确定性，也能通过内部协同优化生产节奏，提升整体运营效率及收益。 智通财经APP讯，巍华新材(603310.SH)发布公告，公司控股子公司浙江方华化学有限公司(以下简称"方 华化学")拟以现金方式收购浙江欣禾生物股份有限公司(以下简称"欣禾生物")持有的江苏禾裕泰化学有 限公司(以下简称"禾裕泰"或"目标公司")70%的股权，交易对价1.54亿元，资金来源为自有资金及银行 贷款。本次交易完成后，禾裕泰将成为公司控股孙公司。 ...

Core Viewpoint - The company plans to use its own funds of 46.5845 million yuan to acquire a 10% stake in Nona Pharmaceutical held by Shangshan Hongren, increasing its ownership in Nona Pharmaceutical from 60% to 70% [1] Group 1: Company Strategy - The transaction aims to consolidate the company's controlling position in Nona Pharmaceutical [1] - This move is part of the company's strategy to deepen its layout in the biopharmaceutical sector [1]

智通财经APP讯，九典制药(300705.SZ)公告，公司拟使用自有资金4658.45万元，收购上善弘仁持有的 诺纳医药10%股权。交易完成后，公司对诺纳医药的持股比例将由60%提升至70%，诺纳医药仍为公司 控股子公司。相关事项旨在巩固对诺纳医药控股地位，进一步深化公司在生物医药领域的战略布局。 ...

和顺石油11月17日公告，公司股票交易连续两个交易日内收盘价格涨幅偏离值累计超过20%，属于股票 交易异常波动情形。公司于2025年11月17日在上海证券交易所网站披露了《关于签署股权收购意向协议 暨关联交易的公告》。公司以现金方式，通过收购股权及增资购买上海奎芯集成电路设计有限公司不低 于34%的股权，同时通过表决权委托，合计控制标的公司51%表决权，即取得标的公司的控制权。双方 确认，标的公司100%的股权价值不高于15.88亿元（增资后估值），预计最终交易金额不高于5.4亿元。 本次签订的意向协议系双方基于收购事项达成的初步意向，具体交易方案、交易金额以最终签署的正式 收购协议为准。 ...

华嵘控股公告称，公司2024年度扣非净利润为负且营收低于3亿，2025年4月29日起实施退市风险警示。 2025年前三季度营收1.09亿元，归母净利润-212.94万元，扣非归母净利润-252.39万元（未审计）。海南 伯程汇能拟协议受让25.01%股份，转让手续进行中，结果未知。11月14日、17日公司股票连续涨停， 价格波动大，提醒投资者注意业绩及二级市场交易风险。 ...

Group 1 - The company held its fourth board meeting on November 14, 2025, where all seven directors attended, and the meeting was deemed legal and effective [2][5] - The board unanimously approved the proposal to sign a share acquisition intention agreement with Shanghai Kuixin Integrated Circuit Design Co., Ltd., aiming to acquire at least 34% of its shares and control 51% of its voting rights [3][32] - The board also approved a proposal to change the business scope, removing "tobacco product retail," which is not expected to significantly impact the company's performance [7][28] Group 2 - The company plans to hold its third extraordinary general meeting on December 5, 2025, with a combination of on-site and online voting to facilitate participation from minority investors [10][12] - The meeting will address the proposals previously approved by the board, including the share acquisition and business scope changes [12][39] Group 3 - The acquisition of Kuixin Technology is part of the company's strategic move into the semiconductor IP sector, which is expected to provide new growth opportunities [32][37] - The total value of Kuixin Technology's 100% equity is not expected to exceed 1.588 billion yuan, with the final transaction amount anticipated to be no more than 540 million yuan [32][47] - The target company has committed to achieving specific revenue and profit targets from 2025 to 2028, with annual revenues set at 300 million yuan, 450 million yuan, 600 million yuan, and 750 million yuan respectively [53][54]